Edition:
United Kingdom

Manojna Maddipatla

Gilead seeks U.S. approval for COVID-19 treatment remdesivir

10 Aug 2020

Gilead Sciences Inc has filed an application with the U.S. Food and Drug Administration seeking full approval for remdesivir, its experimental COVID-19 drug currently used under emergency authorization, the drugmaker said on Monday.

REFILE-UPDATE 3-Alzheimer's drug from Biogen to get speedy U.S. review

07 Aug 2020

Aug 7 The U.S. Food and Drug Administration will conduct an expedited review of an experimental Alzheimer's drug from Biogen Inc and Japan's Eisai Co Ltd, the companies said on Friday, the first application in 17 years to be reviewed by the agency for a treatment of the mind-robbing disease.

State attorneys general urge U.S. to let other firms make Gilead COVID-19 drug

05 Aug 2020

A bipartisan group of state attorneys general urged the U.S. government on Tuesday to allow other companies to make Gilead Sciences' COVID-19 treatment, remdesivir, to increase its availability and lower the price of the antiviral drug.

Fauci says states seeing surge in COVID-19 cases should reconsider some lockdown measures

04 Aug 2020

The U.S. government's top infectious disease expert, Dr. Anthony Fauci, on Monday said states with high coronavirus case counts should reconsider imposing lockdown restrictions, emphasizing the need to get cases to a low baseline before the fall flu season.

UPDATE 1-Fauci says states seeing surge in COVID-19 cases should reconsider some lockdown measures

03 Aug 2020

Aug 3 The U.S. government's top infectious disease expert, Dr. Anthony Fauci, on Monday said states with high coronavirus case counts should reconsider imposing lockdown restrictions, emphasizing the need to get cases to a low baseline before the fall flu season.

Coronavirus spread among children in Georgia youth camp, CDC says

31 Jul 2020

The coronavirus spread to at least 44% of staff and attendees at an overnight youth camp over a week and a half, the U.S. Centers for Disease Control said in a review of an overnight camp in Georgia.

UPDATE 2-AbbVie's Humira powers profit beat as COVID-19 weighs on Botox sales

31 Jul 2020

July 31 AbbVie Inc on Friday posted a quarterly adjusted profit above estimates as robust sales of its blockbuster arthritis treatment, Humira, helped cushion weak demand for its aesthetic drugs, including Botox, due to the COVID-19 pandemic.

Cigna profit gets boost from lower costs as patients delay surgery

30 Jul 2020

Health insurer Cigna Corp beat Wall Street expectations for second-quarter profit on Thursday, helped by lower medical costs from delayed surgical procedures and strong sales from its pharmacy benefits business.

Anthem profit tops expectations as people delay medical care during pandemic

29 Jul 2020

Anthem Inc reported a quarterly profit that topped Wall Street expectations on Wednesday, aided by lower medical costs as people delayed non-essential procedures during the first surge of the U.S. coronavirus outbreak.

World News